Stanford University
Showing 1,001-1,050 of 2,473 Results
-
Michael Christopher Jewett
Professor of Bioengineering and, by courtesy, of Chemical Engineering
BioMichael Jewett is a Professor of Bioengineering at Stanford University. He received his B.S. from UCLA and PhD from Stanford University, both in Chemical Engineering. He completed postdoctoral studies at the Center for Microbial Biotechnology in Denmark and the Harvard Medical School. Jewett was also a guest professor at the Swiss Federal Institute of Technology (ETH Zurich). His research group focuses on advancing synthetic biology research to support planet and societal health, with applications in medicine, manufacturing, sustainability, and education.
-
Saumitra Jha
Associate Professor of Political Economy at the GSB, Senior Fellow at the Freeman Spogli Institute, at the Stanford Institute for Economic Policy Research & Associate Professor, by courtesy, of Political Science and of Economics
BioSaumitra Jha is an Associate Professor of Political Economy at Stanford’s Graduate School of Business, and by courtesy, of Economics and of Political Science. He is also a Senior Fellow at the Center for Democracy, Development and the Rule of Law in the Freeman-Spogli Institute for International Affairs and convenes the Stanford Conflict and Polarization Lab.
Saumitra holds a BA from Williams College, master’s degrees in economics and mathematics from the University of Cambridge, and a PhD in economics from Stanford University. Prior to joining the GSB, he was an Academy Scholar at Harvard University. He has been a Center Fellow at the Center for Advanced Study in the Behavioral Sciences, as well as of the Niehaus Center for Globalization and Governance and the Center for the Study of Democratic Politics at Princeton University. He was voted Teacher of the Year by the students of the Stanford GSB Sloan Fellow Class of 2020. He received the Michael Wallerstein Award for best published article in Political Economy from the American Political Science Association in 2014 for his research on ethnic tolerance and his co-authored work on Heroes was awarded the 2020 Oliver Williamson Best Paper Award from the Society for Institutional and Organizational Economics. -
Hanlee P. Ji
Professor of Medicine (Oncology) and, by courtesy of Electrical Engineering
Current Research and Scholarly InterestsCancer genomics and genetics, translational applications of next generation sequencing technologies, development of molecular signatures as prognostic and predictive biomarkers in oncology, primary genomic and proteomic technology development, cancer rearrangements, genome sequencing, big data analysis
-
Hongchen Jiang
Staff Scientist, Energy Sciences
Current Role at StanfordStaff Scientist
-
Booil Jo
Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsLatent Variable Modeling, Causal Inference, Longitudinal Data Analysis, Missing Data Analysis, Mixture and Growth Mixture Modeling, Prevention Science Methodology.
-
Ramesh Johari
Professor of Management Science and Engineering, Senior Fellow at the Stanford Institute for Human-Centered Artificial Intelligence (HAI) and, by courtesy, of Electrical Engineering
BioJohari is broadly interested in the design, economic analysis, and operation of online platforms, as well as statistical and machine learning techniques used by these platforms (such as search, recommendation, matching, and pricing algorithms).
-
Ann R. Johnson
Associate Vice Provost, Research Compliance, Vice Provost and Dean of Research - Research Compliance
BioDr. Johnson is the Associate Vice Provost for Research Compliance at Stanford University, overseeing both human and animal research compliance programs. She specializes in research ethics and is an expert in human subjects research regulations and requirements. She is an active member of the research community having conducted research in the fields of public health and research ethics. She has taught undergraduate- and graduate-level courses and is an ardent supporter of research education. She participates in many national forums with the federal government, accrediting bodies, commercial IRBs, and academic research institutions to address problems and priorities for research oversight and quality. She helped establish a single IRB process for the University of Utah and the National Center for Advancing Translational Science-funded Trial Innovation Network. She also worked closely with the SMART IRB initiative to provide harmonized guidance on IRB reliance and the functions of human research protection programs. She also serves as a site visitor for the Association for the Accreditation of Human Research Protection Programs.
-
Sarah Johnson
Postdoctoral Scholar, Bioengineering
BioI design and drive studies using wearables that combine modelling, data analysis and software development to address problems that limit human performance.
I have with a particular interest in female health, and work to translate findings into practical solutions. -
Felipe Jornada
Assistant Professor of Materials Science and Engineering
BioFelipe Jornada's research aims at predicting and understanding excited-state phenomena in quantum and energy materials. In order to make reliable predictions on novel materials, he relies on high-performance computer calculations based on parameter-free, quantum-mechanical theories that are developed in his group. He is interested in studying fundamental aspects of these excitations – their lifetimes, dynamics, and stability/binding energies – and how they can be engineered in novel materials, such as nanostructured and low-dimensional systems. His ultimate goal is to use insights from atomistic calculations to rationally design new materials with applications in energy research, electronics, optoelectronics, and quantum technologies.
Felipe received his Ph.D. degree in physics from UC Berkeley in 2017 under the advice of Prof. Steven G. Louie. His Ph.D. research focused on the prediction of the electronic and optical properties of new quasi-two-dimensional materials, such as graphene and monolayer transition metal dichalcogenides. In his postdoc, he studied a number of problems related to multiparticle excitations in low-dimensional materials, including biexcitons and plasmons. Felipe joined the Stanford faculty in January 2020 and an assistant professor in the Department of Materials Science and Engineering. -
Shamit Kachru
Professor of Physics and Director, Stanford Institute for Theoretical Physics, Emeritus
Current Research and Scholarly InterestsMy current research is focused in three directions:
— Mathematical aspects of string theory (with a focus on BPS state counts, black holes, and moonshine)
— Quantum field theory approaches to condensed matter physics (with a focus on physics of non-Fermi liquids)
— Theoretical biology, with a focus on evolution and ecology -
Deborah Kado
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioDr. Kado is a board-certified, fellowship-trained doctor specializing in geriatrics. She serves as co-director of the Stanford Longevity Center. She is a professor of medicine and chief of research for the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health. She is also the Director of the Geriatric Research, Education, and Clinical Center (GRECC) at VA Palo Alto Health Care System.
For each patient, Dr. Kado prepares a personalized care plan. Her objective is to help all individuals maintain the best possible health and quality of life as they age.
A special interest of Dr. Kado is bone health. She has conducted extensive research focused on osteoporosis and the related disorder hyperkyphosis.
Since joining the UCLA faculty in 2000, she has received continuous funding for her research from the National Institutes of Health (NIH).
She has over 100 peer-reviewed publications of her research findings in the Journal of Bone and Mineral Research, Osteoporosis International, Journal of Gerontology and Medical Sciences, Journal of Geriatric Oncology, Nature Communications, and other peer-reviewed journals.
In 2007, she defined hyperkyphosis as a new geriatric syndrome. Her discoveries in this field were first featured in the American College or Physician’s premier internal medicine journal Annals of Internal Medicine. Later, they also appeared in a dedicated chapter in UpToDate, the electronic resource providing evidence-based clinical decision support for doctors worldwide.
Prior to coming to Stanford, Dr. Kado practiced at UC San Diego where she started a dedicated osteoporosis clinic for patient care and research. She later broadened her research interests beyond musculoskeletal aging to study other aging-related topics such as the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.
Dr. Kado is a California native. She trained at UCSF and UCLA. She also earned a Master of Science degree in epidemiology at the UCLA School of Public Health, sponsored by the John Hartford Foundation.
She is a member of the American Geriatrics Society, American Society of Bone and Mineral Research, Gerontological Society of America, The Endocrine Society, and other professional organizations. She co-chairs the NIH National Institute on Aging Workshop for the American Society of Bone and Mineral Research. She also participates in the Bone Health Working Group of the Society for Women’s Health Research. -
Colin Kahl
Director, Freeman Spogli Institute for International Studies, Steven C. Házy Senior Fellow, and Professor, by courtesy, of Political Science
BioColin Kahl is the Steven C. Házy Senior Fellow at Stanford University’s Center for International Security and Cooperation (CISAC), an interdisciplinary research hub in the Freeman Spogli Institute for International Studies. He is also the faculty director of CISAC’s Program on Geopolitics, Technology, and Governance, and a professor of political science (by courtesy).
From April 2021-July 2023, Dr. Kahl served as the Under Secretary of Defense for Policy at the U.S. Department of Defense. In that role, he was the principal adviser to the Secretary of Defense for all matters related to national security and defense policy and represented the Department as a standing member of the National Security Council Deputies’ Committee. He oversaw the writing of the 2022 National Defense Strategy, which focused the Pentagon’s efforts on the “pacing challenge” posed by the PRC, and he led the Department’s response to Russia’s invasion of Ukraine and numerous other international crises. He also led several other major defense diplomacy initiatives, including: an unprecedented strengthening of the NATO alliance; the negotiation of the AUKUS agreement with Australia and the United Kingdom; historic defense force posture enhancements in Australia, Japan, and the Philippines; and deepening defense and strategic ties with India. In June 2023, Secretary of Defense Lloyd Austin III awarded Dr. Kahl the Department of Defense Distinguished Public Service Medal, the highest civilian award presented by the Secretary of Defense.
During the Obama Administration, Dr. Kahl served as Deputy Assistant to President Obama and National Security Advisor to the Vice President Biden from October 2014 to January 2017. He also served as Deputy Assistant Secretary of Defense for the Middle East from February 2009 to December 2011, for which he received the Outstanding Public Service Medal in July 2011.
Dr. Kahl is the co-author (along with Thomas Wright) of Aftershocks: Pandemic Politics and the End of the Old International Order (New York: St. Martin’s Press, 2021) and the author States, Scarcity, and Civil Strife in the Developing World (Princeton, NJ: Princeton University Press, 2006). He has also published numerous article on U.S. national security and defense policy in Foreign Affairs, Foreign Policy, International Security, the Los Angeles Times, Middle East Policy, the National Interest, the New Republic, the New York Times, Politico, the Washington Post, and the Washington Quarterly, as well as several reports for the Center for a New American Security (CNAS), a non-partisan think tank in Washington, DC.
Dr. Kahl previously taught at Georgetown University and the University of Minnesota, and he has held fellowship positions at Harvard University, the Council on Foreign Relations, CNAS, and the Penn Biden Center for Diplomacy and International Engagement.
He received his B.A. in political science from the University of Michigan (1993) and his Ph.D. in political science from Columbia University (2000). -
Joseph Kahn
Harald Trap Friis Professor
BioJoseph M. Kahn is a Professor of Electrical Engineering at Stanford University. His research addresses communication and imaging through optical fibers, including modulation, detection, signal processing and spatial multiplexing. He received A.B. and Ph.D. degrees in Physics from U.C. Berkeley in 1981 and 1986. From 1987-1990, he was at AT&T Bell Laboratories, Crawford Hill Laboratory, in Holmdel, NJ. He was on the Electrical Engineering faculty at U.C. Berkeley from 1990-2003. In 2000, he co-founded StrataLight Communications, which was acquired by Opnext, Inc. in 2009. He received the National Science Foundation Presidential Young Investigator Award in 1991 and is a Life Fellow of the IEEE.
-
A Dale Kaiser
Member, Bio-X
Current Research and Scholarly InterestsHow are genes regulated to construct a developmental program? How do signals received from other cells change the program and coordinate it for multicellular development? The approach taken by our laboratory group to answer these questions utilizes biochemistry and genetics; genetics to isolate mutants that have particular defects in development and biochemistry to determine the molecular basis of the defects. We study swarming in Myxococcus xanthus that builds fruiting bodies.
-
Anusha Kalbasi, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is a physician-scientist at the Stanford Cancer Institute. In the clinic, Dr. Kalbasi is a radiation oncologist specializing in the treatment of patients with sarcoma and other solid tumors, with expertise in early phase clinical trials related to immunotherapy, cellular therapy, and radiation therapy.
The Kalbasi laboratory studies cancer immunology, with a focus on understanding—and re-engineering—the molecular conversations that immune cells have with one another and with cancer cells, especially through cytokines. By mapping how these signals are sent, received, and interpreted within immune cells and cancer cells, the lab aims to design next-generation immunotherapies that deliver the right messages at the right time—making cancer-fighting cells more potent, more persistent, and more precise. -
Julia Kaltschmidt
Professor of Neurosurgery
Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.
-
Robin Kamal MD MBA
Associate Professor of Orthopaedic Surgery and, by courtesy, of Surgery (Plastic and Reconstructive Surgery)
Current Research and Scholarly InterestsWrist and Elbow Injuries and Quality Measures in Orthopaedic Surgery
-
Tahereh Kamali
Instructor, Adult Neurology
Current Research and Scholarly InterestsAI for Healthcare, Neuroimaging, Biomarkers Development
-
Aya Kamaya, MD
Professor of Radiology (Body Imaging)
Current Research and Scholarly InterestsHepatobiliary imaging
Hepatocellular carcinoma
Urologic imaging
Gynecologic imaging
Thyroid imaging
Novel ultrasound technologies
Perfusion CT imaging of abdominal tumors -
Matthew Kanan
Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy
BioMatt Kanan is a Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy at Stanford. Matt’s research group works across multiple fields of chemistry and engineering with applications for sustainable plastics, critical mineral recovery, and carbon management. Their work has led to several inventions in these areas, including new performance-advantaged bioplastics, electrochemical systems to recycle acid and base, metal-free catalysts for C1 transformations, and thermal mineral conversion processes. Matt is the co-founder of ReSource Chemical Corp., an Oakland-based start-up commercializing manufacturing technology developed in his lab, and Mafix, Inc., a spin-out developing mineral fertilizers that remove CO2 from the atmosphere. Prior to joining the Stanford faculty in 2009, Matt did his Ph.D. studies in organic chemistry at Harvard and postdoctoral research at MIT in inorganic chemistry. He earned his B.A. in chemistry from Rice University in 2000.
-
Hyunseok Kang
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research interest lies in development of precision oncology based approaches and novel therapeutics for rare cancers of head and neck, including adenoid cystic cancers, salivary duct cancers, sinonasal cancers and thyroid cancers.
-
Peter Kao
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsOur research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms -
Zerina Kapetanovic
Assistant Professor of Electrical Engineering and, by courtesy, of Computer Science and of Geophysics
BioZerina Kapetanovic is an Assistant Professor in the Department of Electrical Engineering at Stanford University working in the area of low-power wireless communication, sensing, and Internet of Things (IoT) systems. Prior to starting at Stanford, Kapetanovic was a postdoctoral researcher at Microsoft Research in the Networking Research Group and Research for Industry Group.
Kapetanovic's research has been recognized by the Yang Research Award, the Distinguished Dissertation Award from the University of Washington. She also received the Microsoft Research Distinguished Dissertation Grant and was selected to attend the 2020 UC Berkeley Rising Stars in EECS Workshop. Kapetanovic completed her PhD in Electrical Engineering from the University of Washington in 2022. -
Aharon Kapitulnik
Theodore and Sydney Rosenberg Professor of Applied Physics and Professor of Physics
BioAharon Kapitulnik is the Theodore and Sydney Rosenberg Professor in Applied Physics at the Departments of Applied Physics and Physics at Stanford University. His research focuses on experimental condensed matter physics, while opportunistically, also apply his methods to tabletop experimental studies of fundamental phenomena in physics. His recent studies cover a broad spectrum of phenomena associated with the behavior of correlated and disordered electron systems, particularly in reduced dimensions, and the development of effective instrumentation to detect subtle signatures of physical phenomena.
Among other recognitions, his activities earned him the Alfred P. Sloan Fellowship (1986-90), a Presidential Young Investigator Award (1987-92), a Sackler Scholar at Tel-Aviv University (2006), the Heike Kamerlingh Onnes Prize for Superconductivity Experiment (2009), a RTRA (Le Triangle de la Physique) Senior Chair (2010), and the Oliver Buckley Condensed Matter Prize of the American Physical Society (2015). Aharon Kapitulnik is a Fellow of the American Physical Society, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science and a member of the National Academy of Sciences. Kapitulnik holds a Ph.D. in Physics from Tel-Aviv University (1984). -
Spyros Karadimas, MD, PhD
Assistant Professor of Neurosurgery
BioDr. Spyridon Karadimas is a board-certified, fellowship-trained cerebrovascular neurosurgeon and physician-scientist with Stanford Health Care. He is also an assistant professor in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Karadimas offers advanced, personalized treatment for complex vascular disorders of the brain, neck, and spine in both adults and children. His expertise spans brain aneurysms, arteriovenous malformations, cavernous malformations, arteriovenous fistulas, Moyamoya disease, stroke, and carotid artery disease. Dr. Karadimas is a rare combination of surgeon, scientist, and innovator dedicated to advancing patient care and shaping the future of cerebrovascular neurosurgery.
Dr. Karadimas directs a basic and translational research program focused on the neural circuits of motor control and stroke recovery. His laboratory integrates systems neuroscience, in vivo imaging, electrophysiology, and brain-computer interface development to uncover the principles of neuroplasticity, or how the brain adapts to change. This knowledge allows him to create new ways to help people move again after a brain injury.
Dr. Karadimas has published his research as first author in peer-reviewed journals such as Nature, Nature Neuroscience and Science Translational Medicine. His work has received editorial highlight at Nature Reviews Neuroscience. He has presented to his peers at international, national, and regional meetings, including those of the American Academy of Neurological Surgery, American Association of Neurological Surgeons (AANS), European Association of Neurosurgical Societies, and World Federation of Skull Base Societies.
Dr. Karadimas is a fellow of the Royal College of Surgeons of Canada and American Association of Neurological Surgeons as well as member of the Congress of Neurological Surgeons, and the North American Skull Base Society. -
Cansu Karakas
Assistant Professor of Pathology (Clinical Pathology)
BioDr. Cansu Karakas is an Assistant Professor, with subspecialty expertise in Breast Pathology. Her academic career spans notable institutions such as MD Anderson Cancer Center and (2010–2017) and NYU (2017-2018). She is passionate about research with a focus on HER2-driven breast cancers, artificial intelligence (AI) applications in breast cancer and identifying resistance mechanisms to guide novel, personalized therapeutic strategies in breast cancer.
-
Ioannis Karakikes
Associate Professor (Research) of Cardiothoracic Surgery
Current Research and Scholarly InterestsThe Karakikes Lab aims to uncover fundamental new insights into the molecular mechanisms and functional consequences of pathogenic mutations associated with familial cardiovascular diseases.
-
Hemamala Karunadasa
J.G. Jackson and C.J. Wood Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering
BioProfessor Hema Karunadasa works with colleagues in materials science, earth science, and applied physics to drive the discovery of new materials with applications in clean energy. Using the tools of synthetic chemistry, her group designs materials that couple the structural tunability of organic molecules with the diverse electronic and optical properties of extended inorganic solids. This research targets materials such as sorbents for capturing environmental pollutants, phosphors for solid-state lighting, and absorbers for solar cells.
Hemamala Karunadasa studied chemistry and materials science at Princeton University (A.B. with high honors 2003; Certificate in Materials Science and Engineering 2003), where her undergraduate thesis project with Professor Robert J. Cava examined geometric magnetic frustration in metal oxides. She moved from solid-state chemistry to solution-state chemistry for her doctoral studies in inorganic chemistry at the University of California, Berkeley (Ph.D. 2009) with Professor Jeffrey R. Long. Her thesis focused on heavy atom building units for magnetic molecules and molecular catalysts for generating hydrogen from water. She continued to study molecular electrocatalysts for water splitting during postdoctoral research with Berkeley Professors Christopher J. Chang and Jeffrey R. Long at the Lawrence Berkeley National Lab. She further explored molecular catalysts for hydrocarbon oxidation as a postdoc at the California Institute of Technology with Professor Harry B. Gray. She joined the Stanford Chemistry Department faculty in September 2012. Her research explores solution-state routes to new solid-state materials.
Professor Karunadasa’s lab at Stanford takes a molecular approach to extended solids. Lab members gain expertise in solution- and solid-state synthetic techniques and structure determination through powder- and single-crystal x-ray diffraction. Lab tools also include a host of spectroscopic and electrochemical probes, imaging methods, and film deposition techniques. Group members further characterize their materials under extreme environments and in operating devices to tune new materials for diverse applications in renewable energy.
Please visit the lab website for more details and recent news. -
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Riitta Katila
W.M. Keck Professor and Professor of Management Science and Engineering
Current Research and Scholarly InterestsThe question that drives Prof. Katila's research is how technology-based firms with significant resources can stay innovative. Her work lies at the intersection of the fields of technology, innovation, and strategy and focuses on strategies that enable organizations to discover, develop and commercialize technologies. She combines theory with longitudinal large-sample data (e.g., robotics, biomedical, platform and multi-industry datasets), background fieldwork, and state-of-the-art quantitative methods. The ultimate objective is to understand what makes technology-based firms successful.
To answer this question, Prof. Katila conducts two interrelated streams of research. She studies (1) strategies that help firms leverage their existing resources (leverage stream), and (2) strategies through which firms can acquire new resources (acquisition stream) to create innovation. Her early contributions were firm centric while recent contributions focus on innovation in the context of competitive interaction and ecosystems.
Professor Katila's work has appeared in the Academy of Management Journal, Administrative Science Quarterly, Organization Science, Strategic Entrepreneurship Journal, Strategy Science, Strategic Management Journal, Research Policy and other outlets. In her work, supported by the National Science Foundation, Katila examines how firms create new products successfully. Focusing on the robotics and medical device industries, she investigates how different search approaches, such as the exploitation of existing knowledge and the exploration for new knowledge, influence the kinds of new products that technology-intensive firms introduce. -
Daniel Katz
Assistant Professor of Medicine (Computational Medicine)
BioDaniel Katz is an Assistant Professor of Medicine in the Stanford Center for Biomedical Informatics Research (BMIR) and the Cardiovascular Medicine Divisions. He practices as an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. His research focuses on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.
-
Noa Katz
Research Professional, Chemical Engineering
BioNoa Katz is a Stanford Science Fellow and an EMBO and Fulbright postdoctoral scholar at Stanford University. She implements biomolecular gene circuits to study and manipulate the central nervous system to promote therapeutic applications for neural repair and autism.
-
Laurence Katznelson, MD
Professor of Neurosurgery, Emeritus
Current Research and Scholarly InterestsDr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
Amit Kaushal
Adjunct Professor, Bioengineering
BioDr. Kaushal is Clinical Associate Professor of Medicine and Adjunct Professor of Bioengineering at Stanford University. He is a respected internal medicine physician with expertise in applications of computer science, artificial intelligence (AI), and machine learning (ML) to medicine and public health. He has worked in roles ranging from deeply technical to deeply clinical, in both academia and industry.
Dr. Kaushal brings over 20 years of research experience at the intersection of computer science and biomedicine. His work focuses on taking AI/ML applications from concept all the way through live clinical deployment, with attention to fair and ethical use of AI. His work has been featured in JAMA, Nature, Lancet Digital Health, NEJM AI, NEJM Catalyst Innovations in Care Delivery, Nature npj Digital Medicine, JAMA Network Open, Health Affairs Blog, and others; and he has been covered in popular media outlets such as Scientific American, Wired, STAT News, The Verge, LA Times, and more.
Dr. Kaushal launched Stanford University School of Engineering's undergraduate degree program in Biomedical Computation over 20 years ago; he serves as co-director of the major, which has graduated over 150 students since its founding. He is a faculty in the Stanford Center for Artificial Intelligence in Medicine and Imaging, Stanford Institute for Human-Centered Artificial Intelligence, Stanford Clinical Excellence Research Center, and Stanford Partnership for AI-Assisted Care.
Dr. Kaushal practices hospital medicine at VA Palo Alto, where he also serves as inaugural Director of the Amplified Reach Catalyst (ARC) Program, an embedded research-support infrastructure for VA hospitalist clinicians.
Dr. Kaushal has served in executive, operating, and advisory roles in industry.
Dr. Kaushal is board certified in both internal medicine and clinical informatics. He completed his BS (Biomedical Computation), MD, PhD (Biomedical Informatics) and Internal Medicine residency training all at Stanford University. -
Makoto Kawai
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioI am a physician scientist in the field of sleep medicine in aging and brain function. Using combined polysomnogram and novel neuroimaging technology, I aim to identify potential sleep biomarkers to investigate the mechanism of progression from normal aging to Mild Cognitive Impairment (MCI) or dementia. I also investigate the impact of sleep on cognitive/affective function or behavior abnormality in various neurodevelopmental and neurodegenerative disorders.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
